World Aging & Longevity Conference
October 08-10, 2026
Senolytics
Senolytics are interventions that selectively eliminate senescent cells that accumulate with age. Senescent cells contribute to tissue dysfunction through inflammatory signaling and impaired regeneration. By clearing these cells, senolytics aim to reduce chronic inflammation, restore tissue homeostasis, and improve functional outcomes. Senolytic strategies target vulnerabilities unique to senescent cells while sparing healthy cells. Research has shown that removal of senescent cells can improve physical function and delay age-related decline in experimental systems. Senolytics represent a targeted approach to addressing one of the fundamental drivers of aging. Understanding senolytics supports development of therapies that enhance tissue health and resilience.
Kenneth R Pelletier
University of California School of Medicine, United States
Thomas J Webster
Brown University, United States
Jason Beckwith
BioTalent, United Kingdom
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Jose Cordeiro Mateo
International Longevity Summit, Spain
Ashot Khachatryan
National Academy of Sciences of the Republic of Armenia, Armenia
Utpol Das
University of Texas Medical Branch at Galveston, United StatesSubmit your abstract Today
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom